Bio-active Peptide Market

Bio-Active Peptide Market Outlook (2024 to 2034)

The global bio-active peptide will be valued at US$ 2,642.5 million by 2024 end and has been forecasted to expand at a noteworthy CAGR of 5.4 % to end up at US$ 4,450.0 million by 2034. Milk Peptides by Type will be worth around US$ 755.8 million in 2024 and account for a 28.6% share of the global market.

The global market for bioactive peptides is on the increase due to the growing health consciousness among consumers, the expansion in the consumption of functional foods and nutraceuticals, and the positive developments in the technological aspects of peptide synthesis and extraction. Short chains of amino acids, which are called bioactive peptides and originate from proteins, possess various physical activities, such as antibacterial, and antioxidant which are anti-inflammatory, hence their importance in health promotion and in disease prevention.

The aging population across the globe creates a specific demand for bioactive peptides that address aging issues, especially in managing ailments such as cardiovascular diseases and cognitive impairment. Furthermore, the personalization of diet has made consumers favor products with particular health benefits, thereby creating a market for bioactive peptides, which is wider than food that includes drugs and cosmetics.

Report Attributes	Details
Bio-active Peptide Market Size (2023A)	US$ 2,508.3 Million
Estimated Market Value (2024E)	US$ 2,642.5 Million
Forecasted Market Value (2034F)	US$ 4,450.0 Million
Global Market Growth Rate (2024-2034)	5.4% CAGR
East Asia Market Share (2024)	22.4%
United States Market Growth Rate (2024-2034)	5.8% CAGR
Key Companies Profiled	ASF SE; Angel Yeast Co., Ltd.; Seagarden AS; Archer Daniels Midland Company; Ingredia SA; Rousselot S.A.S.; FrieslandCampina Ingredients; Peptan; Kerry Group plc; CP Kelco USA, Inc.; Other Prominent Players

Sales Analysis of Bio-active Peptide (2019 to 2023) vs. Market Forecasts (2024 to 2034)

The value of the bio-active peptide market was US$ 2,013.1 million in 2019 and it will increase to US$ 2,508.3 million by 2023, expanding at a CAGR of 5.4%

• Short Term (2024 to 2028): Between the years 2024 and 2028, an increased use of functional food products, nutraceuticals, and pharmaceuticals has been noted. Along with consumer awareness of healthy lifestyle habits, bioactive peptides are being developed more and marketed for potential health benefits including cardiovascular health, immunoenhancement, and weight management applications. The growing geriatric population and occurrence of chronic diseases in the population is also boosting the demand for bioactive peptides in preventive healthcare systems. Besides, the increasing research and development on therapeutic peptides is also a contributory factor to the growth of the market.
• Medium Term (2028 to 2030): Between the years 2028 and 2030, Plant-based components because, for ethical and allergy-related concerns, more individuals are searching for non-allergic peptide sources these days rather than those obtained from animals. Furthermore, biotechnology has made it possible to find additional sources of peptides and develop better methods for extracting them, which has improved the products' quality and accessibility. Since more people are seeking customized health solutions, the idea of nutrition is likewise becoming more and more ingrained in the market.
• Long Term (2030 to 2034): During the period from 2030 to 2034, the growing consumer awareness of advanced biotechnology applications and specialized precision medicine is expected to fuel the global bioactive peptide market's rapid growth. The competition will be differentiated by the growing usage of bio-engineered peptides for certain therapeutic targets, such as specifically focused drug delivery systems and cancer treatment. Moreover, the heightened regulatory approvals for medications based on peptides would alleviate commercialization obstacles, expanding market opportunities.

On the back of the aforementioned facts, the bio-active peptide market is anticipated to grow at a CAGR of 5.4% during the forecast period from 2024-2034, according to the Fact.MR, a market research and competitive intelligence provider.

Market Dynamics

What are the factors propelling global sales of bio-active peptides?

“Fast-track sanctioning of bioactive peptide-based medications propels market expansion.”

The market is expanding at a rapid rate due to the accelerated approval of bioactive peptide-based drugs as this alleviates the time taken to launch new peptide drugs. Peptides, being drugs, have been associated with a lot of gains by regulatory bodies, especially when it comes to the treatment of ailments such as cancers, metabolic disorders, and even cardiovascular diseases.

Peptide drugs due to their high specificity and low toxicity with less adverse effects than the usually available drugs, the fast-tracking approvals of, has helped the market as it paved way for more pharmaceutical companies to invest in the research and development of peptides. It is also apparent that the fast-tracked approval procedures facilitate the translational aspect of the research on super-potent agents thereby enabling quicker use of those super-potent agents in the form of medications that use peptide compounds.

These features also facilitate the cultivation of new ideas that help in the synthesis and modification of peptides. As regulatory authorities are liberalizing the parameters within which peptide-based drugs are produced, the producers of such drugs are finding it easy to satisfy the unquenchable urge of the consumers due to the therapeutic advancements freshening up the bioactive peptide industry.

“Increasing utilization of bio-active peptides in nutritional supplementation.”

The increasing application of bio-active peptides in dietary supplements is propelling discrimination as a result of the fact that more individuals are focusing on health-enhancing and functional ingredients. They are being incorporated into nutraceuticals and health-related supplements for specific body systems to advance physical well-being.

Such peptides are made of bioavailable food sources such as plant, dairy, or marine protein, which is their appealing factor owing to the health benefits they elicit for specific systems. Growing diseases contributed by changing lifestyles such as obesity, heart-related conditions, and aging, have led consumers to use bio-active peptide supplement-infused products as wellness products.

Moreover, as consumers are increasingly opting for individualized meal plans, designers of dietary supplements are incorporating peptides into the products for various customers’ health and well-being. The manufacturers are taking this opportunity and integrate peptide-based products in various forms such as powders, capsules, and even functional drinks. Another factor enhancing their popularity among consumers and increasing usage of the products in the supplementation market is that bioactive peptides can be easily integrated into everyday food intake.

What are the challenges encountered by manufacturers of bioactive peptides?

“Consumer skepticism towards the efficacy of collagen in the beverage format”

The manufacturing and research of peptides associated to food allergies, which are typically obtained from dairy, soy, shellfish, and other significant food allergens, provide difficulties for producers of bioactive peptides and peptide-based products. These allergens may cause intolerance reactions in specific populations and decrease the market for items that include peptides.

The increasing availability of electrical gadgets specifically made for babies has led to a high demand for allergen-free, health-promoting supplements. According to this rule, the producers of these products must use a variety of marketing methods, such as highlighting the product's peptides' health benefits in contrast to any potential risks to consumers.

The difficulties are further compounded by the authorities' requirements for allergen labels and testing, which raise production costs and complexity. Also, the inclusion of allergens can prevent market access in areas where there are stringent allergen restrictions in place, for example, Europe and North America.

Peptide producers are looking for alternative, non-allergic, and effective peptide sources, such as plants and readily available synthetic alternatives, in light of these difficulties. Theoretically, finding other raw material sources would be easy, but these alternatives are expensive, particularly when it comes to R&D and the purchase of new technology.

Country-wise Insights

How Manufacturers in Germany Differentiate Their Products and Make Sales?

“Stringent Safety and Regulatory Standards Increased Consumer Trust and Boosted Market”

The market in the United States is estimated at US$ 281.0 million in 2024 and is projected to expand at a CAGR of 5.8% through 2034. This market is projected to generate a US$ 493.1 million absolute opportunity from 2024 to 2034.

German bioactive peptide market, the increasing consumer confidence due to the stringent safety and regulatory standards has also fueled the market. However, the strong regulatory framework in Germany, guided by the likes of the Federal Institute for Risk Assessment (BfR), means that only safe and high-quality bioactive peptide products are availed to consumers. This level of scrutiny fosters assurance of the safety and effectiveness of supplements, pharmaceuticals, and functional foods that contain peptides.

In Germany, the manufacturers of these products offer their products with a differentiation strategy based on how well they conform to these rules and use the ‘Made in Germany’ brand as a form of quality and dependability of their products. In addition, they focus on clean labels, product transparency, and allergen-free products in response to the growing appetite for safe and effective health solutions. There is also a large focus in the German manufacturers’ strategies on the development of new peptide-based products that meet preset therapeutic goals such as cardiovascular, immune health, and anti-aging.

What Makes the United States Another Significant Market for Bio-active Peptide?

“Consistent Research Helping to Discover Various Sources of Bioactive Peptides in the United States”

The United States is now in a position to compete internationally thanks to persistent and forward-moving research activities that are leading to the development of many bioactive peptide sources. As more and more unique peptides are found in plants, marine life, and synthetic sources by American research institutes and biotechnology companies, the range of applications for peptides is growing.

In the US, innovation is highly valued, and because there are many resources available for health-oriented research and development, these breakthroughs help to promote functional foods, medications, and customized nutrition. Additionally, consumers' inclination to adopt health-improving bioactive peptides has been influenced by the growth in functional health supplements and preventative healthcare.

The bioactive peptide industry is expected to develop, and American producers are well-positioned to capitalize on this expansion thanks to effective technology infrastructure and a favorable regulatory environment, particularly provided by the FDA. The United States is the most desirable location for the development and commercialization of bioactive peptides due to innovative research, well-designed regulations, and market demand.

Category-wise Insights

Why are plant-based bioactive peptides making more sales?

“The Hypoallergenic Nature of Plant-Based Bioactive Peptides Drives Demand as An Alternative to Animal-Based Peptides. ”

The growing use of hypoallergenic, plant-based bioactive peptides that may be utilized as alternatives to animal proteins is one of the main factors driving the market expansion for bioactive peptides. Because they don't cause allergic reactions, peptides derived from plants like soybeans, rice, and even pea protein are more palatable to those who can't tolerate anything derived from animal proteins. This trend is a response to the notable rise in the number of people following plant-based and vegan diets for ethical, ecological, and health-related reasons.

Unlike animal-produced enzymes like whey protein or casein, which can cause allergic reactions, incoming and outgoing bioactive plant peptides have the same benefits, such as easier digestion, increased immunity, and even faster muscle recovery. Plant-derived bioactive peptides are expected to continue to be used more frequently as a result of consumers' changing lifestyles, which include more active pursuits of health and clean-label components.

What Are the Factors Responsible for Rising Sales of Milk Peptides in The Bio-Active Peptide Market?

“Easy Digestibility and Bioavailability of Milk-Derived Bioactive Peptides Peptide Benefiting the Market”

There is increased global demand for mucosal bioactive peptides, which can be attributed to their high usability, as well as the ease of digestion of such before use. These peptides are naturally contained in milk protein that is used to produce casein and whey. They are ingested to the body and this makes them advantageous in improving heart health, protecting the body from any infections, and even aiding in muscle healing. Efficiency, sustainability, and minimal loss of these resources have therefore rendered these compounds very helpful in nutraceutical and functional food designs.

The other factor driving the expansion of milk bioactive peptides is the general public's growing health consciousness about the need of protein in the diet, particularly among athletes and the elderly. This is especially true for the majority of the world, where these peptides are included in consumers' regular diets due to their functional qualities. The use of milk-derived bioactive peptides in functional meals, nutritional supplements, and food fortification is therefore becoming more and more popular among consumers.

Competitive Landscape & Market Developments

Market players in the bio-active peptide market are ASF SE, Angel Yeast Co., Ltd., Seagarden AS, Archer Daniels Midland Company, Ingredia SA, Rousselot S.A.S., FrieslandCampina Ingredients, Peptan, Kerry Group plc., CP Kelco USA, Inc., and other market players.

• Rousselot S.A.S.: In Jan 2024, The Peptan collagen peptides business of Rousselot S.A.S., a subsidiary of Darling Ingredients, has had strong positive growth, mostly as a result of rising internal demand for sports nutrition and cosmetics. The company reaffirmed its commitment to research and development to expand its line of bioactive peptides.
• Seagarden AS: In May 2023, The Norwegian firm operational in the marine ingredients, has recently launched assets anchored on bio-active peptides obtained from deep sea fish. The company targeted the products on sports nutrition and cognitive health supplements.
• Angel Yeast Co., Ltd.: By Apr 2023, Angel Yeast Co., Ltd. has opened a new research and development center focused on bio-active peptides and other functional ingredients. This investment aimed to enhance the company’s innovative capabilities in the booming health ingredients market.

Fact.MR has provided detailed information about the price points of key manufacturers positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Segmentation of Bio-active Peptide Market Research

• By Type :

  • Milk Peptides
  • Egg Peptides
  • Soy Peptides
  • Marine Peptides
  • Meat Peptides
  • Others

• By Source :

  • Plant
  • Animal
  • Marine

• By Application :

  • Functional Food
  • Dietary Supplements
  • Pharmaceuticals
  • Animal Feed
  • Others

• By Form :

  • Liquid
  • Powder
  • Capsule

• By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa